AR028237A1 - ACETILSALICILIC ACID SOLUTIONS - Google Patents

ACETILSALICILIC ACID SOLUTIONS

Info

Publication number
AR028237A1
AR028237A1 ARP010101068A ARP010101068A AR028237A1 AR 028237 A1 AR028237 A1 AR 028237A1 AR P010101068 A ARP010101068 A AR P010101068A AR P010101068 A ARP010101068 A AR P010101068A AR 028237 A1 AR028237 A1 AR 028237A1
Authority
AR
Argentina
Prior art keywords
acid solutions
acetilsalicilic
acetilsalicilic acid
solutions
acid
Prior art date
Application number
ARP010101068A
Other languages
Spanish (es)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of AR028237A1 publication Critical patent/AR028237A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
ARP010101068A 2000-03-07 2001-03-07 ACETILSALICILIC ACID SOLUTIONS AR028237A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10011032A DE10011032A1 (en) 2000-03-07 2000-03-07 Stable solutions of acetylsalicylic acid in mixture of organic solvent and water, useful for topical treatment of pain, especially pain associated with herpes zoster

Publications (1)

Publication Number Publication Date
AR028237A1 true AR028237A1 (en) 2003-04-30

Family

ID=7633806

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010101068A AR028237A1 (en) 2000-03-07 2001-03-07 ACETILSALICILIC ACID SOLUTIONS

Country Status (9)

Country Link
EP (1) EP1263441A2 (en)
AR (1) AR028237A1 (en)
AU (1) AU2001272099A1 (en)
DE (1) DE10011032A1 (en)
GT (1) GT200100035A (en)
HN (1) HN2001000039A (en)
PE (1) PE20030207A1 (en)
SV (1) SV2002000339A (en)
WO (1) WO2001066115A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070196460A1 (en) * 2004-02-16 2007-08-23 Yukiko Inamoto External preparation for treating skin or mucosal injury caused by viral infection
RU2442578C2 (en) * 2006-05-02 2012-02-20 Пфайнсмит С.А. (Пти) Лтд Acid complex
JP7335232B2 (en) * 2017-05-30 2023-08-29 ローシャン ファーマシューティカルズ，インコーポレーテッド Intravial Deposits of Stable, Sterile and Crystalline O-Acetylsalicylic Acid (Aspirin)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219548A (en) * 1978-09-01 1980-08-26 The Procter & Gamble Company Topical anti-inflammatory composition
IL68965A (en) * 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
SK96196A3 (en) * 1994-01-24 1997-03-05 Procter & Gamble Process for solubilizing difficultly soluble pharmaceutical actives
US5484606A (en) * 1994-01-24 1996-01-16 The Procter & Gamble Company Process for reducing the precipitation of difficulty soluble pharmaceutical actives

Also Published As

Publication number Publication date
AU2001272099A1 (en) 2001-09-17
DE10011032A1 (en) 2001-09-13
WO2001066115A2 (en) 2001-09-13
GT200100035A (en) 2001-12-18
PE20030207A1 (en) 2003-04-16
HN2001000039A (en) 2001-07-09
WO2001066115A3 (en) 2002-02-14
EP1263441A2 (en) 2002-12-11
SV2002000339A (en) 2002-06-07

Similar Documents

Publication Publication Date Title
ATE269861T1 (en) SUBSTITUTED INDOLALKANIC ACID
ATE239005T1 (en) (4-SULFONYLAMINO)-TETRAHYDROPYRAN-4-CARBONIC ACID HYDROXAMIDES
DE60139338D1 (en) BIOPROTHETIC HEARTLAPPING SYSTEM
DE60125769D1 (en) IMPROVED ELECTRONICIZATION SYSTEM
DE10196023T1 (en) Monitoring System
DK1100769T3 (en) aminomethylcarboxylic acid
ATE307121T1 (en) SUBSTITUTED ARYLPYRAZINE
ATE419231T1 (en) MONO-SUBSTITUTED 3-PROPYL-GAMMA-AMINOBUTTERIC ACID
AR028393A1 (en) SUBSTITUTED IMINOAZIDS
AR028410A1 (en) BATTERY MANUFACTURE
NO20024018L (en) Photovoltaics
DE10196082T1 (en) FLIP-CHIP-assembly process
DK1317426T3 (en) Pay-thio-amino acids
AR028302A1 (en) SUBSTITUTED FENILURACILOS
DE50100418D1 (en) BREZEL PRODUCTION SYSTEM
DE60130137D1 (en) CRYSTALLIZATION PROCESS
DK1373135T3 (en) Stabilized hypobromous acid solutions
NO20025542L (en) quinolonecarboxylic acid derivatives
DE50105785D1 (en) WIPER SYSTEM
ATE342328T1 (en) SURFACTANT SYSTEM
DE50104548D1 (en) SOLUTION MEDIATOR
DE50110035D1 (en) WIPER
PT1228026E (en) COMPOUNDS RELATED TO 15-HYDROXYETHYTHETRAENOIC ACID
DE50110033D1 (en) WIPER SYSTEM
AR028237A1 (en) ACETILSALICILIC ACID SOLUTIONS

Legal Events

Date Code Title Description
FB Suspension of granting procedure